A comparison of the pharmacokinetics of oral and sublingual cyproheptadine.
Article Details
- CitationCopy to clipboard
Gunja N, Collins M, Graudins A
A comparison of the pharmacokinetics of oral and sublingual cyproheptadine.
J Toxicol Clin Toxicol. 2004;42(1):79-83. doi: 10.1081/clt-120028749.
- PubMed ID
- 15083941 [ View in PubMed]
- Abstract
BACKGROUND: Cyproheptadine is reported to be effective in treating serotonin syndrome. It is only available as an oral preparation and administration after SSRI overdose treated with activated charcoal is problematic. Sublingual administration may circumvent this problem. The pharmacokinetics of sublingual cyproheptadine are not characterized. This study compares the pharmacokinetics of cyproheptadine following oral and sublingual administration. METHODS: Cross-over, non-blinded, volunteer study using five healthy males. Eight milligrams of oral and sublingual cyproheptadine were administered on separate occasions with a one-week washout period. Sublingual arm subjects were pretreated with 50 g of oral activated charcoal 30 min prior to cyproheptadine, to prevent any gut absorption. Serum cyproheptadine concentration was measured at baseline, 30 min, and 1, 2, 3, 4, 6, 8, and 10 h by liquid chromatography and mass spectroscopy. RESULTS: Mean C(max) for oral and sublingual were 30.0 microg/L and 4.0 microg/L respectively: mean T(max) were 4 h and 9.6 h; mean AUC were 209 and 25 microg x hr/L. Mean +/- SEM within-subject difference between oral and sublingual C(max) was 25.9 +/- 4.1 (p = 0.003) and AUC was 184 +/- 31 (p = 0.004). CONCLUSIONS: Serum concentrations after sublingual cyproheptadine are significantly less than after oral administration. At these concentrations, the sublingual route is unlikely to be effective in treating serotonin syndrome.
DrugBank Data that Cites this Article
- Drugs
- Drug Interactions
Drugs Interaction Integrate drug-drug
interactions in your softwareDesvenlafaxineCyproheptadine The therapeutic efficacy of Desvenlafaxine can be decreased when used in combination with Cyproheptadine. DuloxetineCyproheptadine The therapeutic efficacy of Duloxetine can be decreased when used in combination with Cyproheptadine. EscitalopramCyproheptadine The therapeutic efficacy of Escitalopram can be decreased when used in combination with Cyproheptadine. FluvoxamineCyproheptadine The therapeutic efficacy of Fluvoxamine can be decreased when used in combination with Cyproheptadine. MilnacipranCyproheptadine The therapeutic efficacy of Milnacipran can be decreased when used in combination with Cyproheptadine.